Early hope: can a new drug rally the Body's defenses against a devastating brain virus?
NCT ID NCT04781309
Summary
This small, early-stage study tested if a drug called NT-I7 could help people with a rare and serious brain infection called PML. PML happens when the immune system is weak. Researchers gave NT-I7 to 12 adults with PML to see if it safely increased their infection-fighting white blood cells, which might help their bodies control the virus. The main goal was to learn how the drug affects cell counts to plan future research.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.